Compound Detail
CHEMBL518520
RALTEGRAVIR POTASSIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+]
Basic Information
| ChEMBL ID | CHEMBL518520 |
| Name | RALTEGRAVIR POTASSIUM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IFUKBHBISRAZTF-UHFFFAOYSA-M |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL254316 |
| Active Moiety | CHEMBL254316 |
4
Targets
19
Activities
2
Assay Types
11
PK Parameters
17
Publications
11
Known Names
3
Indications
1
Mechanisms
Molecular Properties
444.4
MW (Da)
0.91
ALogP
9
HBA
3
HBD
152.2
PSA (Ų)
0.51
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2007 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Human immunodeficiency virus type 1 integrase inhibitor | INHIBITOR | Human immunodeficiency virus type 1 integrase | ✓ | ✓ |
Indications
Autoimmune Diseases HIV Infections HIV Infections
Activity Summary
EC50 13 meas. best 9.59
IC50 6 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 9.59 | 8.565 | 0.3 | 12 |
| Human immunodeficiency virus CHEMBL613758 | IC50 | 8.7 | 8.425 | 2.0 | 2 |
| Human immunodeficiency virus type 1 integrase CHEMBL3471 | IC50 | 8.48 | 7.73 | 3.3 | 3 |
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Human immunodeficiency virus 2 CHEMBL380 | EC50 | 7.8 | 7.8 | 16.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 577.75 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 4888.62 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 19998.9 | ng.hr.mL-1 | Macaca mulatta |
| Cmax | 1600.0 | nM | Rattus norvegicus |
| Cmax | 4600.0 | nM | Canis lupus familiaris |
| Cmax | 24000.0 | nM | Canis lupus familiaris |
| F | 45.0 | % | Rattus norvegicus |
| F | 69.0 | % | Canis lupus familiaris |
| F | - | % | Macaca mulatta |
| T1/2 | 7.5 | hr | Rattus norvegicus |
| T1/2 | 13.0 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21115794 | 10.1128/aac.01209-10 | Human immunodeficiency virus 1 | 66 |
| 18763751 | 10.1021/jm800245z | Canis familiaris | 7 |
| 18763751 | 10.1021/jm800245z | Rattus norvegicus | 4 |
| 23845180 | 10.1021/jm400645w | Human immunodeficiency virus | 4 |
| 18763751 | 10.1021/jm800245z | Rhesus monkey | 3 |
| 28951095 | 10.1016/j.bmc.2017.09.006 | Unchecked | 2 |
| 22369862 | 10.1016/j.ejmech.2012.02.015 | Human immunodeficiency virus 1 | 2 |
| 20727748 | 10.1016/j.bmcl.2010.07.079 | Human immunodeficiency virus 1 | 2 |
| 19523819 | 10.1016/j.bmcl.2009.05.098 | Human immunodeficiency virus 1 | 2 |
| 21115794 | 10.1128/aac.01209-10 | Human immunodeficiency virus type 1 integrase | 1 |
| 20727748 | 10.1016/j.bmcl.2010.07.079 | Human immunodeficiency virus type 1 integrase | 1 |
| 22608761 | 10.1016/j.ejmech.2012.04.020 | Human immunodeficiency virus | 1 |
| 19523819 | 10.1016/j.bmcl.2009.05.098 | Human immunodeficiency virus type 1 integrase | 1 |
| 28951095 | 10.1016/j.bmc.2017.09.006 | Human immunodeficiency virus 1 | 1 |
| 28951095 | 10.1016/j.bmc.2017.09.006 | Human immunodeficiency virus 2 | 1 |
| 28951095 | 10.1016/j.bmc.2017.09.006 | MT4 | 1 |
| 18763751 | 10.1021/jm800245z | Human immunodeficiency virus 1 | 1 |
Data from ChEMBL 36 via Core Engine